Nationale Nederlanden Powszechne Towarzystwo Emerytalne S.A. Intra Cellular Therapies, Inc. Transaction History
Nationale Nederlanden Powszechne Towarzystwo Emerytalne S.A.
- $721 Billion
- Q3 2024
A detailed history of Nationale Nederlanden Powszechne Towarzystwo Emerytalne S.A. transactions in Intra Cellular Therapies, Inc. stock. As of the latest transaction made, Nationale Nederlanden Powszechne Towarzystwo Emerytalne S.A. holds 404,656 shares of ITCI stock, worth $35 Million. This represents 4.11% of its overall portfolio holdings.
Number of Shares
404,656Holding current value
$35 Million% of portfolio
4.11%Shares
1 transactions
Others Institutions Holding ITCI
# of Institutions
398Shares Held
87.5MCall Options Held
309KPut Options Held
302K-
Vanguard Group Inc Valley Forge, PA9.61MShares$831 Million0.01% of portfolio
-
Black Rock Inc. New York, NY6.32MShares$547 Million0.01% of portfolio
-
Wasatch Advisors Inc Salt Lake City, UT3.72MShares$322 Million1.37% of portfolio
-
Jpmorgan Chase & CO New York, NY3.44MShares$297 Million0.02% of portfolio
-
Avoro Capital Advisors LLC New York, NY3MShares$260 Million2.8% of portfolio
About Intra-Cellular Therapies, Inc.
- Ticker ITCI
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 94,401,696
- Market Cap $8.17B
- Description
- Intra-Cellular Therapies, Inc., a biopharmaceutical company, develops novel drugs for the treatment of neuropsychiatric and neurologic diseases by targeting intracellular signaling mechanisms within the central nervous system in the United States. The company offers CAPLYTA for the treatment of schizophrenia in adults. It is also involved in dev...